{{Rsnum
|rsid=4645878
|Gene=BAX
|Chromosome=19
|position=48954681
|Orientation=plus
|GMAF=0.09275
|Gene_s=BAX
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 21.2 | 76.1
| HCB | 0.0 | 10.2 | 89.8
| JPT | 0.0 | 3.5 | 96.5
| YRI | 1.4 | 14.3 | 84.4
| ASW | 0.0 | 14.0 | 86.0
| CHB | 0.0 | 10.2 | 89.8
| CHD | 0.0 | 8.3 | 91.7
| GIH | 1.0 | 5.0 | 94.1
| LWK | 0.9 | 13.6 | 85.5
| MEX | 8.6 | 29.3 | 62.1
| MKK | 1.3 | 16.7 | 82.1
| TSI | 2.0 | 16.7 | 81.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=22568453
|Title=Association of CASP3 polymorphism with hematologic toxicity in advanced NSCLC patients treated with platinum-based chemotherapy
}}

{{PMID Auto
|PMID=19700502
|Title=Synopsis and synthesis of candidate-gene association studies in chronic lymphocytic leukemia: the CUMAGAS-CLL information system.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}